Rhumbline Advisers »

Aeglea Biotherapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.3M 58k 23.28
2024-09-30 $1.6M 54k 29.41
2024-06-30 $1.2M 52k 23.51